PureWeld XL tubing stands up to technical challenges of continuous bioprocessing
A recent study from Watson-Marlow Fluid Technology Group (WMFTG), demonstrates that PureWeld® XL tubing offers extended lifespan and steady flow consistency when compared to other leading brands.
Continuous processing has the potential to significantly increase the efficiency of biologics manufacture, reducing production costs and the price of pharmaceuticals. In order to achieve this, all single-use components must be able to maintain integrity for extended production cycles of up to 90 days. Manufacturers must therefore consider the practical performance of every component when planning their production.
This study from WMFTG compares the peristaltic life and pumping performance of three SEBS Based thermoplastic elastomer (TPE) tubing products. PureWeld XL tubing demonstrated significantly longer peristaltic life and sustained pumping performance when compared with the two other leading brands.
PureWeld XL tubing demonstrated significantly longer peristaltic life
Dr Chris Palmer, Tubing Product Manager at WMFTG, commented, “This recent study confirms the need for drug manufacturers to consider the lifespan and quality of all components when designing a continuous bioprocessing system.
WMFTG is always seeking to improve its offerings to satisfy future customer requirements across multiple industries, including biopharmaceutical manufacturing.
The growing adoption of single-use technologies in bioprocessing has propelled tubing from a minor to a major component of the manufacturing process, and the results of these tests demonstrate the benefits of choosing PureWeld XL tubing for the production of new medicines.”